Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06784375 · ClinicalTrials.gov registry record · NA
Personalized Nutrition for Type 2 Diabetes
A NA study of Type 2 Diabetes, sponsored by University of Minnesota.
- Recruiting
- Registry status
- NA
- Development phase
- 72
- Enrollment target
- 1
- Study location
NCT06784375: Recruiting NA study of Type 2 Diabetes, sponsored by University of Minnesota.
NCT06784375 is a NA study of Type 2 Diabetes that is actively recruiting participants, run by University of Minnesota. The registered enrollment target is 72 participants, below the 3,923-participant average among 327 other Type 2 Diabetes trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06784375, a NA study of Type 2 Diabetes, is actively recruiting participants, sponsored by University of Minnesota.
- RECRUITING
- Registry status
- NA
- Development phase
- 72 participants
- Enrollment target
- 1
- Study location
Study Summary
This project will compare medical nutrition therapy personalized by continuous glucose monitor (CGM) feedback to control interventions in participants with type 2 diabetes mellitus (T2DM).
Primary Outcome
Measure of blood glucose control
Conditions Studied
Interventions
- BEHAVIORAL Unblinded CGM/Nutrition Therapy
- BEHAVIORAL Blinded CGM/Nutrition Therapy
- BEHAVIORAL Unblinded CGM/No Nutrition Therapy
- BEHAVIORAL Blinded CGM/No Nutrition Therapy
Study Locations (1)
Minnesota
- University of Minnesota - Minneapolis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 72 participants |
| Start Date | 2025-07-14 |
| Est. Completion | 2027-08-01 |
| Phase | NA |
What NCT06784375 shows while recruiting
NCT06784375 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 72 participants, a relatively small participant target, below the 3,923-participant average among 327 other Type 2 Diabetes trials with a reported enrollment target (98% lower).
The record links to 1 condition, with Type 2 Diabetes appearing as the primary indexed condition, and to 4 interventions - of which Unblinded CGM/Nutrition Therapy is the first listed.
NCT06784375 reports a single indexed study location in Minnesota.
Frequently Asked Questions
What is clinical trial NCT06784375 about?
NCT06784375 is a clinical study titled "Personalized Nutrition for Type 2 Diabetes". This project will compare medical nutrition therapy personalized by continuous glucose monitor (CGM) feedback to control interventions in participants with type 2 diabetes mellitus (T2DM).
What is the current status of trial NCT06784375?
This trial is currently recruiting. It is a NA study. The enrollment target is 72 participants. The study started on 2025-07-14. Estimated completion is 2027-08-01.
What conditions does trial NCT06784375 study?
This clinical trial studies the following conditions: Type 2 Diabetes.
What interventions are being tested in trial NCT06784375?
The interventions under investigation include: Unblinded CGM/Nutrition Therapy (BEHAVIORAL), Blinded CGM/Nutrition Therapy (BEHAVIORAL), Unblinded CGM/No Nutrition Therapy (BEHAVIORAL), Blinded CGM/No Nutrition Therapy (BEHAVIORAL).
Who is sponsoring clinical trial NCT06784375?
This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06784375 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Type 2 Diabetes
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06784375's enrollment target sits among peer trials
72 182nd of 327 higher than 146 of 327 other Type 2 Diabetes trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Type 2 Diabetes trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Enhancing Telemedicine for T2D
RECRUITING · NA
-
Sleep and Glycemic Control in Type 2 Diabetes Adolescents
RECRUITING · NA
-
Enhancing Preventative Health Behaviors Among Emergency Department Hyperglycemic Patients
RECRUITING · NA
-
Ultrasound Effects on Glycemic Control in T2DM
RECRUITING · NA
-
A Randomized Double-Blinded and Placebo-Controlled Trial to Assess the Efficacy of Biophoton Therapy to Treat Type 2 Diabetes
RECRUITING · NA
-
High Fructose Diet, the Gut Microbiome, and Metabolic Health
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02359253 · 72 participants · NA
Robot Aided Rehabilitation - Intervention
- NCT02962661 · 72 participants · Phase 1
Donor Bone Marrow Derived Mesenchymal Stem Cells in Controlling Heart Failure in Patients With Cardiomyopathy Caused by Anthracyclines
- NCT03113643 · 72 participants · Phase 1
SL-401 in Combination With Azacitidine or Azacitidine/Venetoclax in Acute Myeloid Leukemia (AML), High-Risk Myelodysplastic Syndrome (MDS) or Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
- NCT03187535 · 72 participants · NA
Effect of TEAS on PONV After Spinal Surgery
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI